C World Wide Group Holding A Paratek Pharmaceuticals, Inc. Transaction History

C World Wide Group Holding A

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$3.47 - $6.32 $1.63 Million - $2.97 Million	-470,150 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$4.8 - $11.6 $183,033 - $442,331	-38,132 Reduced 7.5%	470,150 $2.41 Million
Q3 2018 Nov 05, 2018	SELL	$9.05 - $10.95 $252,006 - $304,913	-27,846 Reduced 5.19%	508,282 $4.93 Million
Q2 2018 Aug 03, 2018	BUY	$10.2 - $13.9 $386,325 - $526,462	37,875 Added 7.6%	536,128 $5.47 Million
Q1 2018 May 03, 2018	SELL	$12.65 - $18.85 $1.48 Million - $2.2 Million	-116,647 Reduced 18.97%	498,253 $6.48 Million
Q4 2017 Feb 07, 2018	SELL	$17.45 - $25.6 $526,990 - $773,120	-30,200 Reduced 4.68%	614,900 $11 Million
Q3 2017 Nov 06, 2017	BUY	$18.9 - $28.2 $12.2 Million - $18.2 Million	645,100	645,100 $16.2 Million

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.